February 2017
J2786 replaces J3490, J3590 when billing for Cinqair® (reslizumab)
The Centers for Medicare & Medicaid Services has established a permanent procedure code for specialty medical drug Cinqair® (reslizumab), effective Jan. 1, 2017.
All services from June 1, 2016, through Dec. 31, 2016, will continue to be reported with codes J3490 and J3590. All services performed on and after Jan. 1, 2017, must be reported with J2786.
Specialty pharmacy prior authorization is required for all groups unless they have opted out of the Prior Authorization program.
|